Health & Wellness Akero Therapeutics nearly doubles stock price on positive clinical studies MASH is a more severe form of metabolic dysfunction-associated steatotic liver disease formerly known as non-alcoholic fatty liver disease Joseph MortonJanuary 27, 2025
Medical and Pharmaceutical Expanding access: LillyDirect offers Zepbound directly to patients Eli Lilly introduces direct-to-patient portal for obesity drug access Zartasha MushtaqFebruary 9, 2024
Health & Wellness Vivos Therapeutics new device could provide substantial relief for migraine sufferers The device works by gently repositioning the lower jaw to help open up the airway Joseph MortonMay 2, 2023